Clincosm LogoSign in Get a demo

advanced cancer

Showing 51 - 75 of 482
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Advanced Cancer, Advanced Solid Tumor, Cancer Trial in Scottsdale, San Antonio (STC-15)

Recruiting
  • Advanced Cancer
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Dec 18, 2022

Pulmonary Tumor, Advanced Cancer, Locally Advanced Cancer Trial in Shanghai (Surgery)

Recruiting
  • Pulmonary Neoplasm
  • +2 more
  • Surgery
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai JiaoTong University School of Medicine
Dec 15, 2022

Advanced Cancer Trial in Worldwide (FOCUS+ (face-to-face nurse-led intervention), iFOCUS (web-based intervention))

Recruiting
  • Advanced Cancer
  • FOCUS+ (face-to-face nurse-led intervention)
  • iFOCUS (web-based intervention)
  • Gent, Belgium
  • +12 more
Dec 13, 2022

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (TJ210001)

Completed
  • Solid Tumor
  • +2 more
  • Aurora, Colorado
  • +3 more
Dec 9, 2022

Advanced Cancer, Lymphoma, Solid Tumor Trial in Edinburgh, Newcastle, Oxford (NUC-7738)

Recruiting
  • Advanced Cancer
  • +2 more
  • Edinburgh, United Kingdom
  • +2 more
Dec 7, 2022

Advanced Cancer Trial in Worldwide (Avelumab, Utomilumab, PF-04518600)

Active, not recruiting
  • Advanced Cancer
  • Encinitas, California
  • +87 more
Dec 7, 2022

Advanced Cancer, Metastatic Solid Tumor Trial in New York (Repotrectinib, Irinotecan and temozolomide)

Recruiting
  • Advanced Cancer
  • Metastatic Solid Tumor
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Dec 1, 2022

Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))

Completed
  • Advanced Cancer
  • CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
  • Taichung, Taiwan
  • +1 more
Nov 25, 2022

Advanced Cancer Trial in Australia, United Kingdom, United States (LY3475070, Pembrolizumab)

Completed
  • Advanced Cancer
  • Denver, Colorado
  • +11 more
Nov 24, 2022

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Active Cancer, Active Cancer Treatment, Advanced Cancer Trial in Boston, Methuen, Londonderry (STAMP+CBT application)

Recruiting
  • Active Cancer
  • +4 more
  • STAMP+CBT application
  • Boston, Massachusetts
  • +2 more
Nov 17, 2022

Advanced Cancer Trial in Durham (Couple Communication Skills Training, Healthy Lifestyle Information)

Recruiting
  • Advanced Cancer
  • Couple Communication Skills Training
  • Healthy Lifestyle Information
  • Durham, North Carolina
    Duke University Medical Center
Nov 14, 2022

Cancer, End Stage Cancer, Malignancy Trial in Baltimore (Community Health Worker (CHW) based palliative care)

Enrolling by invitation
  • Cancer
  • +3 more
  • Community Health Worker (CHW) based palliative care
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Nov 8, 2022

Advanced Cancer Trial in Durham (pING-hHER3FL)

Recruiting
  • Advanced Cancer
  • pING-hHER3FL
  • Durham, North Carolina
    Duke University Medical Center
Nov 4, 2022

Advanced Cancer, Brain Metastases Trial in New Orleans (DM-CHOC-PEN)

Completed
  • Advanced Cancer
  • Brain Metastases
  • New Orleans, Louisiana
    Tulane University Medical Center
Nov 3, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Advanced Cancer Trial in New Orleans, Detroit (4-Demethyl-4-cholesteryloxycarbonylpenclomedine)

Completed
  • Advanced Cancer
  • New Orleans, Louisiana
  • +2 more
Nov 3, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Advanced Cancer Trial in Australia (AK-105)

Active, not recruiting
  • Advanced Cancer
  • AK-105
  • Darlinghurst, New South Wales, Australia
  • +4 more
Oct 20, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Cervical Cancer, Advanced Cancer Trial in Romania, Spain, Turkey (No Further Treatment, TSR-042)

Recruiting
  • Cervical Cancer
  • Advanced Cancer
  • Elche, Alicante, Spain
  • +28 more
Oct 17, 2022